Parece que JavaScript está deshabilitado en su navegador. Para obtener la mejor experiencia en nuestro sitio, asegúrese de activar Javascript en su navegador.
FUB-AMB aka MMB-FUBINACA and AMB-FUBINACA is a potent agonist of the CB1 and CB2 receptors, is indazole-based and was developed by Pfizer in 2009 but never made it into trials.
